Result of AGM

GlaxoSmithKline PLC
23 May 2007

Issued - Wednesday 23 May 2007, London - LSE Announcement





GlaxoSmithKline plc - Results of AGM



GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all
resolutions, including those electing and re-electing Board members, were passed
by shareholders.



GlaxoSmithKline Annual General Meeting Poll Results



The following table shows the votes cast for each resolution:


         Resolution           Total votes for   %       Total votes       %    Total votes cast  Votes withheld*
                                     *                    against                                       *
 1   Adoption of Financial     3,974,777,303  97.25     112,587,685      2.75    4,087,364,988     131,974,680
     Statements
 2   Approval of the           3,866,957,876  92.55     311,262,740      7.45    4,178,220,616     41,119,052
     Remuneration
     Report
 3   Election of Dr Daniel     4,192,687,457  99.56      18,368,765      0.44    4,211,056,222      8,283,446
     Podolsky
 4   Election of Dr Stephanie  4,193,211,732  99.58      17,869,645      0.42    4,211,081,377      8,258,291
     Burns
 5   Re-election of Mr Julian 4,116,329,899   98.76      51,698,507      1.24    4,168,028,406     51,311,262
     Heslop
 6   Re-election of Sir        4,188,397,114  99.46      22,585,922      0.54    4,210,983,036      8,356,632
     Deryck Maughan
 7   Re-election of Dr         3,997,639,779  95.69     179,982,624      4.31    4,177,622,403     41,717,265
     Ronaldo Schmitz
 8   Re-election of Sir        4,018,143,686  96.17     160,162,071      3.83    4,178,305,757     41,033,911
     Robert Wilson
 9   Re-appointment of         4,146,391,497  99.43      23,955,388      0.57    4,170,346,885     48,992,783
     Auditors
 10  Remuneration of Auditors  4,170,216,315  99.34      27,602,092      0.66    4,197,818,407     21,521,261
 11  To authorise the company  4,102,268,011  97.50     105,273,773      2.50    4,207,541,784     11,797,884
     to make
     donations to EU
     Political
     Organisations & incur EU
     Political
     Expenditure
 12  Authority to allot        4,157,415,520  98.81      50,020,654      1.19    4,207,436,174     11,903,494
     shares
 13  Disapplication of         4,155,355,020  98.81      50,115,737      1.19    4,205,470,757     13,868,911
     pre-emption
     rights***
 14  Authority for the         4,199,430,372  99.69      12,966,339      0.31    4,212,396,711      6,942,957
     Company to
     purchase its own shares*
     **
 15  Amendment to Articles of  4,182,378,461  99.89      4,757,469       0.11    4,187,135,930     32,203,738
     Association***





Notes:

*               Includes discretionary votes.

**     A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "For" or "Against" a resolution.

***    Indicates Special Resolutions requiring a 75% majority



The following table provides further relevant information:




                                                        GlaxoSmithKline's       GlaxoSmithKline's

                                                        Seventh AGM (2007)      Sixth AGM (2006)


Issued share capital                                      5,725,158,425           5,820,406,967

(excluding Treasury Shares)


Total votes cast and votes withheld lodged as a % of          73.68%                 71.77%
GSK's issued share capital (excluding Treasury
Shares).


Total shareholder population.                                180,486                 192,331


Total number of proxies lodged.                               14,357                 15,907


% of shareholders who lodged proxies.                         7.95%                   8.27%


Number of shareholders,  corporate representatives             276                     290
and proxies who attended the AGM





S M Bicknell

Company Secretary

23 May 2007



These results will shortly be available on the Company's website www.gsk.com.




Enquiries:         UK Media                         Philip Thomson        [phone]

                                                    Joss Mathieson        [phone]

                                                    Gwenan White          [phone]



                   US Media                         Nancy Pekarek         [phone]

                                                    Alice Hunt            [phone]

                                                    Mary Anne Rhyne       [phone]



                   European Analyst / Investor      Anita Kidgell          [phone]

                                                    David Mawdsley         [phone]

                                                    Sally Ferguson         [phone]

                   US Analyst / Investor            Frank Murdolo         [phone]

                                                    Tom Curry             [phone]






                      This information is provided by RNS
            The company news service from the London Stock Exchange